Stem Cell Stocks Take Off (ASTM, GERN, OPXA, STEM) Posted: December 2, 2009 at 3:35 pm
Print Email Subscribe Free Newsletter Follow us on Twitter 24/7 Wall St Real Time 500 Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%. The movement followed a release from the National Institutes of Health (NIH) announcing that 13 embryonic stem cell lines were approved for funding.
Opexa Therapeutics Inc (NASDAQ: OPXA) led the rise in stem cell stocks, surging over 40%. The company seeks to develop treatments to major illnesses, such as multiple sclerosis and diabetes, through stem cell research. The company’s stock has risen 2837% off its lows for the year.
StemCells Inc (NASDAQ: STEM) rose over 30% to a high of $1.45. The company engages in research aimed at developing treatment for organ damage using stem cells. The company’s stock is up over 1544% off its low for the year.
Garrett W. McIntyre
Posted by BooDog on :
watching ISCO .60 As of October 26, 2009, there were 66,568,005 shares of the registrant’s common stock outstanding. And just put ATHX on the watchlist. Very low volume and still researching. The number of outstanding shares of the registrant’s common stock, $0.001 par value, as of October 31, 2009 was 18,929,333. I'm still rolling with a couple other stem cells and gene therapy companies. Nice to see some recovery!
Posted by IWISHIHAD on :
Gern looks like they got their clinical trial.
Ought to be interesting to see how it turns out.
Should go up or down hard depending on what happens.
That should happen shortly.
-
Posted by BooDog on :
I've been watching GERN and STEM, even did a flip on ACTC some of the stem cell stocks have had a bit of a rally on GERN's news imo.